摘要
目的本研究拟探索在体内和体外过表达VHL蛋白能否抑制结肠癌的生长和转移。方法 应用含有VHL的腺病毒在体外及体内过表达VHL蛋白。在体外检测结肠癌细胞CT26的增殖、凋亡和迁移,应用Western blot检测相关蛋白的表达。建立结肠癌皮下移植瘤和肝转移癌模型并判断治疗效果。结果过表达VHL蛋白通过调控COX-2、Bcl-2和MMP-9的表达抑制结肠癌细胞CT26增殖和侵袭,促进CT26细胞凋亡。在体内过表达VHL蛋白可抑制结肠癌皮下移植瘤的增长和结肠癌的肝转移。结论 过表达VHL蛋白可抑制结肠癌的增长和转移,促进结肠癌细胞凋亡,提示VHL可能作为结肠癌治疗的一个潜在靶点。
Objective To investigate whether overexpression of VHL can inhibit the growth and metastasis of colon cancer.Methods Adenovirus vectors containing VHL were used to overexpress VHL protein in vitro and in vivo.The proliferation,apoptosis and migration of colon cancer cells CT26 were examined in vitro.The expressions of related proteins were detected by Western blot analysis.Subcutaneous and liver metastasis of colon cancer models were established and the therapeutic effects were evaluated.Results Overexpression of VHL protein inhibited the proliferation and invasion of CT26,and promoted the apoptosis of CT26 via the regulation of COX-2,Bcl-2 and MMP-9.Overexpression of VHL protein inhibited the growth of subcutaneous colon cancer and liver metastasis in vivo.Conclusion Overexpression of VHL protien can inhibit the growth and metastasis of colon cancer,and enhance the apoptosis of colon cancer,indicating that VHL can be used as a potential target for colon cancer therapy.
引文
1 Lonser RR,Glenn GM,Walther M,et al.von Hippel-Lindau disease[J].Lancet,2003,361(9374):2059-2067.
2 Maxwell PH.Wiesener MS,Chang GW,et al.The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis[J].Nature,1999,399(6733):271-275.
3 Yang H,Minamishima YA,Yan Q,et al.pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2[J].Mol Cell,2007,28(1):15-27.
4 Kurban G,Duplan E,Ramlal N,et al.Collagen matrix assembly is driven by the interaction of von Hippel—Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2[J].Oncogene,2008,27(7):1004-1012.
5 Wang J,Ma Y,Jiang H,et al.Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice[J].J Hepatol,2011,55(2):359-368.
6 Giles RH,Lolkema MP,Snijckers CM,et al.Interplay between VHL/HIF1 alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis[J].Oncogene,2006,25(21):3065-3070.
7 Karanikas M,Esebidis A.Increasing incidence of colon cancer in patients<50 years old:a new entity[J].Ann Transl Med,2016,4(9):164-172.
8 Kelly ME,Spolverato G,Le GN,et al.Synchronous colorectal liver metastasis;a network meta-analysis review comparing classical,combined,and liver-first surgical strategies[J].J Surg Oncol,2015,111(3):341-351.
9 Sonoshita M.Takaku K,Sasaki N,et al.Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Ape(Delta 716)knockout mice[J].Nat Med,2001,7(9):1048-1051.
10 Arber N,Eagle CJ,Spicak J,et al.Celecoxib for the prevention of colorectal adenomatous polyps[J].N Engl J Med,2006,355(9):885-895.
11 Sanchez-Lopez E,Flashner-Abramson E,Shalapour S,et al.Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling[J].Oncogene,2016,35(20):2634-244.
12 Bodur C,Kutuk 0,Karsli-Uzunbas G,et al.Pramanicin analog induces apoptosis in human colon cancer cells:critical roles for Bcl-2,Bim,and p38 MAPK signaling[J].PLoS One,2013,8(2):e56369.
13 Struckmann K,Mertz K,Steu S,et al.pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma[J].J Pathol,2008,214(4):464-471.
14 Mroczko B.Groblewska M,Okulczyk B,et al.The diagnostic value of matrix metalloproteinase 9(MMP-9)and tissue inhibitor of matrix metalloproteinases 1(TIMP-1)determination in the sera of colorectal adenoma and cancer patients[J].Int J Colorectal Dis,2010,25(10):1177-1184.
15 Ishizaki T,Katsumata K,Tsuchida A,et al.Etodolac,a selective cyclooxygenase-2 inhibitor,inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity[J].Int J Mol Med,2006,17(2):357-362.
